← FDA Drug Approvals (Drugs@FDA)

VASOPRESSIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMPHASTAR PHARMS INC · Approved 2022-07-18

Drug application

FDA Application #

ANDA211857

Application type

Abbreviated New Drug Application (Generic)

Brand name

VASOPRESSIN

Generic name

VASOPRESSIN

Active ingredients

VASOPRESSIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

AMPHASTAR PHARMS INC

Manufacturer

Amphastar Pharmaceuticals, Inc.

First approval

2022-07-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown